LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Payne, Rebecca P. / Longet, Stephanie / Austin, James A. / Skelly, Donal T. / Dejnirattisai, Wanwisa / Adele, Sandra / Meardon, Naomi / Faustini, Sian / Al-Taei, Saly / Moore, Shona C. / Tipton, Tom / Hering, Luisa M. / Angyal, Adrienn / Brown, Rebecca / Nicols, Alexander R. / Gillson, Natalie / Dobson, Susan L. / Amini, Ali / Supasa, Piyada /
Cross, Andrew / Bridges-Webb, Alice / Reyes, Laura Silva / Linder, Aline / Sandhar, Gurjinder / Kilby, Jonathan A. / Tyerman, Jessica K. / Altmann, Thomas / Hornsby, Hailey / Whitham, Rachel / Phillips, Eloise / Malone, Tom / Hargreaves, Alexander / Shields, Adrian / Saei, Ayoub / Foulkes, Sarah / Stafford, Lizzie / Johnson, Sile / Wootton, Daniel G. / Conlon, Christopher P. / Jeffery, Katie / Matthews, Philippa C. / Frater, John / Deeks, Alexandra S. / Pollard, Andrew J. / Brown, Anthony / Rowland-Jones, Sarah L. / Mongkolsapaya, Juthathip / Barnes, Eleanor / Hopkins, Susan / Hall, Victoria / Dold, Christina / Duncan, Christopher J.A. / Richter, Alex / Carroll, Miles / Screaton, Gavin / de Silva, Thushan I. / Turtle, Lance / Klenerman, Paul / Dunachie, Susanna / Abuelgasim, Hibatullah / Adland, Emily / Adlou, Syed / Akther, Hossain Delowar / Alhussni, Ahmed / Ali, Mohammad / Ansari, M. Azim / Arancibia-Cárcamo, Carolina V. / Bayley, Martin / Brown, Helen / Chalk, Jeremy / Chand, Meera / Chawla, Anu / Chinnakannan, Senthil / Cutteridge, Jospeh / de Lara, Catherine / Denly, Lucy / Diffey, Ben / Dimitriadis, Stavros / Drake, Thomas M. / Donnison, Timothy / Dupont, Maeva / Eyre, David / Fairman, Alex / Gardiner, Siobhan / Gilbert-Jarmillo, Javier / Goulder, Philip / Hackstein, Carl-Philipp / Hambleton, Sophie / Haniffa, Muzlifah / Haworth, Jenny / Holmes, Jennifer / Horner, Emily / Jämsén, Anni / Jones, Chris / Kasanyinga, Mwila / Kelly, Sinead / Kirk, Rosemary / Knight, Michael L. / Lawrie, Allan / Lee, Lian / Lett, Lauren / Lillie, Katy / Lim, Nicholas / Mehta, Hema / Mentzer, Alexander J. / O’Donnell, Denise / Ogbe, Ane / Pace, Matthew / Payne, Brendan A.I. / Platt, Gareth / Poolan, Sonia / Provine, Nicholas / Ramamurthy, Narayan / Robinson, Nichola / Romaniuk, Leigh / Rongkard, Patpong / Sampson, Oliver L. / Simmons, Beatrice / Spegarova, Jarmila S. / Stephenson, Emily / Subramaniam, Kris / Thaventhiran, James / Thomas, Sarah / Travis, Simon / Tucker, Stephanie / Turton, Helena / Watson, Adam / Watson, Lisa / Weeks, Esme / Wilson, Robert / Wood, Steven / Wright, Rachel / Xiao, Huiyuan / Zawia, Amira A.T.

Cell. 2021 Nov. 11, v. 184, no. 23

2021  

Abstract: Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United ... ...

Institution on behalf of the PITCH Consortium
Abstract Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United Kingdom healthcare workers. The first vaccine dose induced protection from infection from the circulating alpha (B.1.1.7) variant over several weeks. In a substudy of 589 individuals, we show that this single dose induces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (NAb) responses and a sustained B and T cell response to the spike protein. NAb levels were higher after the extended dosing interval (6–14 weeks) compared with the conventional 3- to 4-week regimen, accompanied by enrichment of CD4⁺ T cells expressing interleukin-2 (IL-2). Prior SARS-CoV-2 infection amplified and accelerated the response. These data on dynamic cellular and humoral responses indicate that extension of the dosing interval is an effective immunogenic protocol.
Keywords Severe acute respiratory syndrome coronavirus 2 ; health services ; immunogenicity ; interleukin-2 ; vaccines ; United Kingdom
Language English
Dates of publication 2021-1111
Size p. 5699-5714.e11.
Publishing place Elsevier Inc.
Document type Article
ZDB-ID 187009-9
ISSN 1097-4172 ; 0092-8674
ISSN (online) 1097-4172
ISSN 0092-8674
DOI 10.1016/j.cell.2021.10.011
Shelf mark
Z 75/702: Show issues
Z 93: Show issues
Database NAL-Catalogue (AGRICOLA)

More links

Kategorien

To top